PetMed Express, Inc.
PETS
$1.77
-$0.02-1.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -15.65% | -21.75% | -23.57% | -22.70% | -14.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -15.65% | -21.75% | -23.57% | -22.70% | -14.74% |
| Cost of Revenue | -18.81% | -12.91% | -18.64% | -22.03% | 0.93% |
| Gross Profit | -8.25% | -41.38% | -33.87% | -24.34% | -37.46% |
| SG&A Expenses | -41.63% | 18.47% | 6.39% | 47.87% | 3.72% |
| Depreciation & Amortization | 17.02% | 51.26% | 37.39% | 32.66% | 9.45% |
| Other Operating Expenses | -- | -- | -- | -- | 100.00% |
| Total Operating Expenses | -27.09% | -2.07% | -9.90% | -6.02% | 4.13% |
| Operating Income | 70.31% | -4,240.25% | -932.21% | -249.48% | -533.30% |
| Income Before Tax | 30.41% | -4,256.20% | -1,020.11% | -824.60% | -71.90% |
| Income Tax Expenses | -101.80% | -97.63% | 100.64% | -99.06% | 268.62% |
| Earnings from Continuing Operations | 65.12% | -1,392.64% | -466.29% | -1,009.75% | -132.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.12% | -1,392.64% | -466.29% | -1,009.75% | -132.14% |
| EBIT | 70.31% | -4,240.25% | -932.21% | -249.48% | -533.30% |
| EBITDA | 86.24% | -699.33% | -293.76% | -171.87% | -825.98% |
| EPS Basic | 65.77% | -1,364.43% | -461.29% | -999.18% | -129.91% |
| Normalized Basic EPS | 81.97% | -31,240.00% | -683.16% | -238.08% | -650.46% |
| EPS Diluted | 65.72% | -1,364.43% | -472.73% | -1,016.67% | -126.13% |
| Normalized Diluted EPS | 81.97% | -31,240.00% | -694.28% | -240.94% | -650.46% |
| Average Basic Shares Outstanding | 1.91% | 1.81% | 1.41% | 1.18% | 0.95% |
| Average Diluted Shares Outstanding | 1.91% | 1.81% | -0.24% | -0.89% | 0.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 0.93% | -1.08% | -1.00% | 0.88% |